Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000123342 | SCV000166661 | likely benign | Familial cancer of breast | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000164965 | SCV000215657 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000123342 | SCV000488091 | likely benign | Familial cancer of breast | 2015-12-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000430555 | SCV000524582 | likely benign | not specified | 2017-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000164965 | SCV000690915 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-20 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000123342 | SCV004019632 | benign | Familial cancer of breast | 2023-03-31 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV003422008 | SCV004141319 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | PALB2: BP4, BP7 |
Prevention |
RCV004530059 | SCV004740693 | likely benign | PALB2-related disorder | 2019-04-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |